{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:45:56Z","timestamp":1790660756330,"version":"4.1.0"},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2007,1,29]],"date-time":"2007-01-29T00:00:00Z","timestamp":1170028800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tissue Antigens"],"published-print":{"date-parts":[[2007,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The nonclassical human leukocyte antigen (HLA)\u2010E and \u2010G molecules have previously been shown to inhibit natural killer\u2010 and cytotoxic T\u2010lymphocyte\u2010mediated cell lysis and have also been shown to prevent the proliferation of CD4 T cells and secrete cytokines that appear to be important in the modulation of the Behcet\u2019s disease (BD) immune systems. Polymorphisms in the <jats:italic>HLA\u2010E <\/jats:italic>and <jats:italic>HLA\u2010G <\/jats:italic>genes have been associated with differential expression and function. Thus, we conducted an analysis of the <jats:italic>HLA\u2010E <\/jats:italic>and <jats:italic>HLA\u2010G <\/jats:italic>alleles using Amplification Refractory Mutation System\u2010polymerase chain reaction (PCR) and PCR\u2010restriction fragment length polymorphism techniques in a study comprising 312 patients with BD and 486 controls. The <jats:italic>HLA\u2010E*0101 <\/jats:italic>and <jats:italic>HLA\u2010G*010101 <\/jats:italic>alleles were associated with a reduced risk of BD (<jats:italic>P <\/jats:italic>= 0.0002, odds ratio (OR) = 0.7 and <jats:italic>P <\/jats:italic>= 0.002, OR = 0.7, respectively). By way of contrast, the variants <jats:italic>HLA\u2010E*010302<\/jats:italic>, <jats:italic>HLA\u2010G*010102<\/jats:italic>, <jats:italic>G*0105N <\/jats:italic>alleles and <jats:italic>3741_3754ins14bp <\/jats:italic>were all associated with an increased risk of BD (<jats:italic>P <\/jats:italic>&lt; 0.0001, OR = 1.6; <jats:italic>P <\/jats:italic>= 0.002, OR = 1.8; <jats:italic>P <\/jats:italic>= 0.024, OR = 2.0 and <jats:italic>P <\/jats:italic>= 0.003, OR = 1.4, respectively). Individuals carrying both the <jats:italic>HLA\u2010E*0101 <\/jats:italic>and the <jats:italic>HLA\u2010G*010101 <\/jats:italic>alleles evidenced significantly lower frequency in the patients than in the controls (35.6% <jats:italic>vs <\/jats:italic>49.6%; <jats:italic>P <\/jats:italic>&lt; 0.0001, OR = 0.6). These results indicate that variant HLA\u2010E and HLA\u2010G molecules appear to function independently and synergistically, increasing the risk of BD, and may result in an imbalance of lymphocytic functions, which may culminate in the development of BD.<\/jats:p>","DOI":"10.1111\/j.1399-0039.2006.00742.x","type":"journal-article","created":{"date-parts":[[2007,1,29]],"date-time":"2007-01-29T13:28:58Z","timestamp":1170077338000},"page":"139-144","source":"Crossref","is-referenced-by-count":60,"title":["<i>HLA\u2010E*0101 <\/i>and <i>HLA\u2010G*010101 <\/i>reduce the risk of Behcet\u2019s disease"],"prefix":"10.1111","volume":"69","author":[{"given":"K. S.","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,29]]},"reference":[{"issue":"34","key":"e_1_2_6_2_2","first-page":"S45","article-title":"The level of soluble granzyme A is elevated in the plasma and in the Vg9\/Vd2 T cell culture supernatants of patients with active Behcet\u2019s disease","volume":"22","author":"Accardo\u2010Palumbo A","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.3121\/cmr.4.2.147"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-003-0352-x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02688.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199909)42:9<1961::AID-ANR23>3.0.CO;2-7"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1312"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.9.5199"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.5.2878"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2003.11.153"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830240127"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1431057100"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199809)28:09<2854::AID-IMMU2854>3.0.CO;2-W"},{"key":"e_1_2_6_14_2","first-page":"70","article-title":"Activation of NK cells by an endocytosed receptor for soluble HLA\u2010G","volume":"44","author":"Rajagopalan S","year":"2006","journal-title":"PLoS Biol"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6100"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS19990334"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020797"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199902)29:02<537::AID-IMMU537>3.0.CO;2-6"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208268200"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00251-003-0547-z","article-title":"HLA\u2010G allelic variants are associated with differences in the HLA\u2010G mRNA isoform profile and HLA\u2010G mRNA levels","volume":"55","author":"Hviid TV","year":"2003","journal-title":"Immunogenetics"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gah035"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2003.08.347"},{"key":"e_1_2_6_23_2","first-page":"1078","article-title":"Criteria for diagnosis of Behcet\u2019s disease","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","journal-title":"Lancet"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(00)00200-7"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2003.09.019"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.2002.600202.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmi048"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(00)00190-7"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.8755-8920.2001.450308.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(97)00008-6"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.7.1093"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2005.12.003"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-001-0373-0"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2000.00109.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-0039.2001.057001015.x"}],"container-title":["Tissue Antigens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0039.2006.00742.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0039.2006.00742.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T21:49:09Z","timestamp":1696888149000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0039.2006.00742.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,29]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["10.1111\/j.1399-0039.2006.00742.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0039.2006.00742.x","archive":["Portico"],"relation":{},"ISSN":["0001-2815","1399-0039"],"issn-type":[{"value":"0001-2815","type":"print"},{"value":"1399-0039","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,29]]}}}